Purple Biotech
PPBT
5 hedge funds and large institutions have $87K invested in Purple Biotech in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
35% less capital invested
Capital invested by funds: $134K → $87K (-$47K)
38% less funds holding
Funds holding: 8 → 5 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$25.9K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$13.9K |
| 3 |
KWM
Kingsview Wealth Management
Grants Pass,
Oregon
|
+$3.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$47K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$14K |
| 3 |
MC
Menta Capital
San Francisco,
California
|
-$13K |
| 4 |
BAM
Bruderman Asset Management
Locust Valley,
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $55K | +$25.9K | +13 | +81% |
|
|
KWM
2
Kingsview Wealth Management
Grants Pass,
Oregon
| $16K | +$3.98K | +2 | +33% |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $14K | +$13.9K | +7 | New |
|
|
ASN
4
Advisory Services Network
Atlanta,
Georgia
| $1K | – | – | – |
|
5
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
|
VF
6
Virtu Financial
New York
| – | -$47K | -19 | Closed |
|
|
MC
7
Menta Capital
San Francisco,
California
| – | -$13K | -6 | Closed |
|
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$14K | -6 | Closed |
|
|
BAM
9
Bruderman Asset Management
Locust Valley,
New York
| – | -$2K | -1 | Closed |
|
PPBT Hedge Fund Activity: Q2 2019 in Review
5 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q2 2019, worth a combined $87K — down 35% from $134K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PPBT and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Morgan Stanley, adding an estimated $25.9K. The largest seller was Virtu Financial, exiting entirely with an estimated $47K sold.
- 5 institutional investors held Purple Biotech (PPBT) as of Q2 2019, down from 8 in Q1 2019.
- Funds reported $87K of Purple Biotech stock for Q2 2019, down 35% quarter-over-quarter.
- 1 fund opened new Purple Biotech positions in Q2 2019 and 4 closed out, a net change of -3 holders.
- The largest Purple Biotech buyer in Q2 2019 was Morgan Stanley, an estimated $25.9K added.
- The largest Purple Biotech seller in Q2 2019 was Virtu Financial, an estimated $47K sold.
Based on aggregated 13F filings for Q2 2019.